The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
The Role of Inflammation in Diabetic Retinopathy
Open accessAbstract
Inflammation is central to pathogenic processes in diabetes mellitus and the metabolic syndrome and particularly implicates innate immunity in the development of complications. Inflammation is a primary event in Type 1 diabetes where infectious (viral) and / or autoimmune processes initiate disease; in contrast, chronic inflammation is typical in Type 2 diabetes and is considered a sequel to increasing insulin resistance and disturbed glucose metabolism. Diabetic retinopathy (DR) is perceived as a vascular and neurodegenerative disease which occurs after some years of poorly controlled diabetes. However, many of the clinical features of DR are late events and reflect the nature of the retinal architecture and its cellular composition. Retinal microvascular disease is, in fact, an early event pathogenetically, induced by low grade, persistent leukocyte activation which causes repeated episodes of capillary occlusion and, progressive, attritional retinal ischemia. The later, overt clinical signs of DR are a consequence of the retinal ischemia. Metabolic dysregulation involving both lipid and glucose metabolism may lead to leukocyte activation. On a molecular level, we have shown that macrophage-restricted protein tyrosine phosphatase 1B (PTP1B) is a key regulator of inflammation in the metabolic syndrome involving insulin resistance and it is possible that PTP1B dysregulation may underlie retinal microvascular disease. We have also shown that adherent CCR5+CD11b+ monocyte macrophages appear to be selectively involved in retinal microvascular occlusion. In this review, we discuss the relationship between early leukocyte activation and the later features of DR, common pathogenetic processes between diabetic microvascular disease and other vascular retinopathies, the mechanisms whereby leukocyte activation is induced in hyperglycemia and dyslipidemia, the signaling mechanisms involved in diabetic microvascular disease, and possible interventions which may prevent these retinopathies. We also address a possible role for adaptive immunity in DR. Although significant improvements in treatment of DR have been made with intravitreal anti-VEGF therapy, a sizeable proportion of patients, particularly with sight-threatening macular edema, fail to respond. Alternative therapies targeting inflammatory processes may offer an advantage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–234 of 234
Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review
Elkjaer, A. S., Lynge, S. K., & Grauslund, J. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14377 · Cited by 31
Bhatwadekar, A. D., Duan, Y., Korah, M. M., Thinschmidt, J. S., Hu, P., Leley, S. P., Caballero, S., Shaw, L. C., Busik, J. V., & Grant, M. B. (2017) · Vision Research · doi:10.1016/j.visres.2017.06.016 · Cited by 30
Chen, M., Obasanmi, G., Armstrong, D., Lavery, N.-J., Kissenpfennig, A., Lois, N., & Xu, H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1533-1 · Cited by 30
Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis
Mozetic, V., Pacheco, R. L., Latorraca, C. D. O. C., & Riera, R. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0488-9 · Cited by 30
A key role for PTP1B in dendritic cell maturation, migration, and T cell activation
Martín‐Granados, C., Prescott, A. R., Sommer, S. L., Klaska, I. P., Tian, Y., Muckersie, E., Giuraniuc, C. V., Grant, L., Delibegović, M., & Forrester, J. V. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv032 · Cited by 28
Self-citationT cell-driven initiation and propagation of autoimmune diabetes
Bettini, M., & Vignali, D. A. A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.10.002 · Cited by 28
Breznik, J. A., Naidoo, A., Foley, K. P., Schulz, C., Lau, T. C., Loukov, D., Sloboda, D. M., Bowdish, D. M. E., & Schertzer, J. D. (2018) · Physiological Reports · doi:10.14814/phy2.13937 · Cited by 28
Ibrahim, A. S., Saleh, H., El‐Shafey, M., Hussein, K. A., Elmasry, K., Baban, B., Sheibani, N., Wang, M.-H., Tawfik, A. M., & Al‐Shabrawey, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.03.010 · Cited by 27
Glycemic reduction alters white blood cell counts and inflammatory gene expression in diabetes
Fang, X., Dorcely, B., Ding, X.-P., Yin, S., Son, N.-H., Hu, S., & Goldberg, I. J. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.003 · Cited by 27
Caruana, B. T., Byrne, F. L., Knights, A. J., Quinlan, K. G. R., & Hoehn, K. L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801063 · Cited by 27
Retinal Endothelial Cell Apoptosis Stimulates Recruitment of Endothelial Progenitor Cells
Bhatwadekar, A. D., Glenn, J. V., Curtis, T. M., Grant, M. B., Stitt, A. W., & Gardiner, T. A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3616 · Cited by 26
Imaging of cellular aging in human retinal blood vessels
Catita, J., López‐Luppo, M., Ramos, D., Nacher, V., Navarro, M., Carretero, A., Sánchez‐Chardi, A., Mendes-Jorge, L., Rodríguez‐Baeza, A., & Ruberte, J. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.03.019 · Cited by 26
G protein-coupled receptor 91 signaling in diabetic retinopathy and hypoxic retinal diseases
Hu, J., Li, T., Du, X., Wu, Q. E., & Le, Y.-Z. (2017) · Vision Research · doi:10.1016/j.visres.2017.05.001 · Cited by 26
Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes
de Oliveira, V. D. N., Neto, A. B. M. L., van Tilburg, M. F., Monteiro‐Moreira, A. C. D. O., Lobo, M. D. P., Rondina, D., Fernandes, V. O., Montenegro, A. P., Montenegro, R. M., & Guedes, M. I. F. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s162008 · Cited by 26
Tryggestad, J. B., Shah, R. D., Braffett, B. H., Bacha, F. F., Gidding, S. S., Gubitosi‐Klug, R., SHAH, A. S., Urbina, E. M., Katz, L. E. L., & for the TODAY Study Group (2020) · Pediatric Diabetes · doi:10.1111/pedi.13062 · Cited by 26
Anti-endothelial cell antibodies in insulin-dependent diabetes mellitus
Wangel, A. G., Kontiainen, S., Scheinin, T. M., Schlenzka, A., WANGEL, D., & Mäenpää, J. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb06463.x · Cited by 25
Verkauskienė, R., Danytė, E., Dobrovolskienė, R., Stankutė, I., Šimonienė, D., Ražanskaitė-Virbickienė, D., Šeibokaitė, A., Urbonaitė, B., Jurgevičienė, N., Vitkauskienė, A., et al. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0145-3 · Cited by 25
Dietary modulation of energy homoeostasis and metabolic-inflammation
Roche, H. M. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002872 · Cited by 25
Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance
Beckles, Z., Edge, J., Mugglestone, M. A., Murphy, M. S., & Wales, J. K. (2016) · BMJ · doi:10.1136/bmj.i139 · Cited by 24
Fenofibrate for Diabetic Retinopathy
Stewart, S., & Lois, N. (2018) · Asia-Pacific Journal of Ophthalmology · doi:10.22608/apo.2018288 · Cited by 24
MacKinnon, J. R. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.040329 · Cited by 23
Antimyeloperoxidase antibody is a biomarker for progression of diabetic retinopathy
Sinha, S., Saxena, S., Das, S. K., Prasad, S., Bhasker, S. K., Mahdi, A. A., & Kružliak, P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.010 · Cited by 18
Latent viruses can cause disease by disrupting the competition for the limiting factor p300/CBP
Polansky, H., & Schwab, H. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0121-1 · Cited by 14
Dysregulation of monocyte biology in metabolic syndrome
Jialal, I., Devaraj, S., & Rajamani, U. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.890046 · Cited by 13
Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
Pafili, K., Παπάνας, Ν., & Maltezos, E. S. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.947026 · Cited by 13
Myeloid cells contribute indirectly to VEGF expression upon hypoxia via activation of Müller cells
Nürnberg, C., Kociok, N., Brockmann, C., Lischke, T., Crespo‐Garcia, S., Reichhart, N., Wolf, S. A., Baumgrass, R., Eming, S. A., Beer‐Hammer, S., et al. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.10.011 · Cited by 13
Yoshitake, S., Murakami, T., Suzuma, K., Yoshitake, T., Uji, A., Morooka, S., Dodo, Y., Fujimoto, M., Shan, Y., Fort, P. E., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4773-1 · Cited by 13
Sodium‐glucose co‐transporters and diabetic nephropathy: Is there a link with toll‐like receptors?
Jigheh, Z. A., Haghjo, A. G., Argani, H., & Sanajou, D. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13261 · Cited by 12
Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex
Bettini, M. L., & Bettini, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00351 · Cited by 11
Samuels, I. S., Portillo, J. C., Miao, Y., Kern, T. S., & Subauste, C. S. (2017) · Visual Neuroscience · doi:10.1017/s0952523817000074 · Cited by 10
Sané, F., Bertin, A., Sioofy‐Khojine, A., Oikarinen, S., Alidjinou, E. K., Veijola, R., Toppari, J., Ilonen, J., Knip, M., Engelmann, I., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3305 · Cited by 10
Herrero, D., Cañón, S., Albericio, G., Carmona, R. M., Aguilar, S., Mañes, S., & Bernad, A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101156 · Cited by 9
Anti-Hexokinase 1 Antibody as a Novel Serum Biomarker of a Subgroup of Diabetic Macular Edema
Yoshitake, T., Murakami, T., Yoshitake, S., Suzuma, K., Dodo, Y., Fujimoto, M., Ito, S., & Tsujikawa, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-39777-z · Cited by 8
Schelp, F. P., Kraiklang, R., Muktabhant, B., Chupanit, P., & Sanchaisuriya, P. (2019) · F1000Research · doi:10.12688/f1000research.19781.1 · Cited by 6
Cited by
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 300
Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment
Xiong, P., Zhang, F., Liu, F., Zhao, J., Huang, X., Luo, D., & Guo, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114545 · Cited by 59
Metadata
- Authors
- Forrester, J. V., Kuffova, L., & Delibegovic, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-06
- Volume
- 11
- Pages
- 583687-583687
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3088840355
- Cited by
- 432
- References
- 234
- FWCI
- 28.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.